Livforsakringsbolaget Skandia Omsesidigt Invests $516,000 in Option Care Health, Inc. $OPCH

Key Points

• Livforsakringsbolaget Skandia Omsesidigt invested approximately $516,000 in Option Care Health, purchasing 15,900 shares during the second quarter.
• Analyst reports have upgraded Option Care Health with target prices as high as $38.00, reflecting a consensus rating of "Moderate Buy".
• The company reported a quarterly revenue of $1.42 billion, surpassing analyst expectations and showing a year-over-year revenue growth of 15.4%.

Livforsakringsbolaget Skandia Omsesidigt bought a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 15,900 shares of the company's stock, valued at approximately $516,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Northwestern Mutual Wealth Management Co. grew its holdings in Option Care Health by 1,492.9% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock worth $31,000 after acquiring an additional 836 shares during the last quarter. Brooklyn Investment Group grew its holdings in Option Care Health by 186.6% during the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock worth $42,000 after acquiring an additional 780 shares during the last quarter. Public Employees Retirement System of Ohio raised its holdings in Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after purchasing an additional 332 shares during the last quarter. Bessemer Group Inc. grew its position in shares of Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after buying an additional 599 shares during the period. Finally, Wealthquest Corp purchased a new position in Option Care Health during the 1st quarter worth $66,000. Institutional investors own 98.05% of the company's stock.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Norman L. Wright bought 3,411 shares of the firm's stock in a transaction that occurred on Tuesday, September 9th. The shares were bought at an average price of $29.31 per share, with a total value of $99,976.41. Following the purchase, the director owned 15,501 shares of the company's stock, valued at $454,334.31. This trade represents a 28.21% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Timothy P. Sullivan bought 20,000 shares of the firm's stock in a transaction that occurred on Thursday, August 21st. The shares were acquired at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the purchase, the director directly owned 49,229 shares in the company, valued at $1,354,289.79. This trade represents a 68.43% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 59,411 shares of company stock valued at $1,627,576 over the last quarter. 0.64% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on OPCH. Citigroup restated an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. JMP Securities upped their target price on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research note on Thursday, July 31st. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research note on Thursday, July 10th. Eight investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, Option Care Health has a consensus rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Stock Performance

NASDAQ:OPCH traded down $0.10 on Friday, hitting $28.31. The stock had a trading volume of 3,364,853 shares, compared to its average volume of 1,677,985. The stock has a market cap of $4.59 billion, a price-to-earnings ratio of 22.65, a price-to-earnings-growth ratio of 1.72 and a beta of 0.82. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. The business's 50-day simple moving average is $28.83 and its two-hundred day simple moving average is $31.23. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.01. The business had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The business's revenue for the quarter was up 15.4% on a year-over-year basis. During the same period last year, the firm posted $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, research analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.